MHC class II auto-antigen presentation is unconventional

被引:26
|
作者
Sadegh-Nasseri, Scheherazade [1 ]
Kim, AeRyon [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA
来源
FRONTIERS IN IMMUNOLOGY | 2015年 / 6卷
关键词
auto-antigens; immunodominance; HLA-DR antigens; cathepsin sensitivity; extracellular processing; paralyzed DC; cell free antigen-processing system; LYSOSOMAL CYSTEINE PROTEASES; DIABETOGENIC T-CELLS; CATHEPSIN-S; HLA-DM; ANTIGEN PRESENTATION; MOUSE MODEL; PEPTIDE; INSULIN; MOLECULES; SELECTION;
D O I
10.3389/fimmu.2015.00372
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigen presentation is highly critical in adoptive immunity. Only by interacting with antigens presented by major histocompatibility complex class II molecules, helper T cells can be stimulated to fight infections or diseases. The degradation of a full protein into small peptide fragments bound to class II molecules is a dynamic, lengthy process consisting of many steps and chaperons. Deregulation in any step of antigen processing could lead to the development of self-reactive T cells or defective immune response to pathogens. Indeed, human leukocyte antigens class II genes are the predominant contributors to susceptibility to autoimmune diseases. Conventional antigen-processing calls for internalization of extracellular antigens followed by processing and epitope selection within antigen-processing subcellular compartments, enriched with all necessary accessory molecules, processing enzymes, and proper pH and denaturing conditions. However, recent data examining the temporal relationship between antigen uptakes, processing, and epitope selection revealed unexpected characteristics for auto-antigenic epitopes, which were not shared with antigenic epitopes from pathogens. This review provides a discussion of the relevance of these findings to the mechanisms of autoimmunity.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [41] Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
    Thibodeau, Jacques
    Bourgeois-Daigneault, Marie-Claude
    Lapointe, Rejean
    ONCOIMMUNOLOGY, 2012, 1 (06): : 908 - 916
  • [42] PRESENTATION OF ENDOGENOUS CYTOSOLIC ANTIGEN BY CLASS-II MHC MOLECULES
    LONG, EO
    MALNATI, MS
    LAVAUTE, T
    CEMAN, S
    DEMARS, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 59 - 59
  • [43] HLA-DM and the MHC class II antigen presentation pathway
    Peter E. Jensen
    Dominique A. Weber
    Wesley P. Thayer
    Xinjian Chen
    Chin T. Dao
    Immunologic Research, 1999, 20 : 195 - 205
  • [44] Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus
    Johnson, DC
    Hegde, NR
    VIRAL PROTEINS COUNTERACTING HOST DEFENSES, 2002, 269 : 101 - 115
  • [45] MHC CLASS-II INVARIANT CHAINS IN ANTIGEN PROCESSING AND PRESENTATION
    KOCH, N
    LIPP, J
    PESSARA, U
    SCHENCK, K
    WRAIGHT, C
    DOBBERSTEIN, B
    TRENDS IN BIOCHEMICAL SCIENCES, 1989, 14 (09) : 383 - 386
  • [46] Targeting antigen to MHC class I and class II antigen presentation pathways for malaria DNA vaccines
    Dobano, Carlota
    Rogers, William O.
    Gowda, Kalpana
    Doolan, Denise L.
    IMMUNOLOGY LETTERS, 2007, 111 (02) : 92 - 102
  • [47] THE ROLE OF AUTO-ANTIGEN IN AUTOIMMUNITY
    ROITT, IM
    COOKE, A
    IMMUNOLOGY LETTERS, 1987, 16 (3-4) : 259 - 263
  • [48] Fc receptors for IgG and antigen presentation on MHC class I and class II molecules
    Amigorena, S
    Bonnerot, C
    SEMINARS IN IMMUNOLOGY, 1999, 11 (06) : 385 - 390
  • [49] Antigen targeting to MHC class I and MHC class Ii presentation pathways of enterocytes in inflammatory bowel disease
    Büning, J
    Schmitz, M
    Hundorfean, G
    Strobel, S
    Zimmer, KP
    Gebert, A
    Ludwig, D
    GASTROENTEROLOGY, 2005, 128 (04) : A502 - A502
  • [50] Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
    Wieczorek, Marek
    Abualrous, Esam T.
    Sticht, Jana
    Alvaro-Benito, Miguel
    Stolzenberg, Sebastian
    Noe, Frank
    Freund, Christian
    FRONTIERS IN IMMUNOLOGY, 2017, 8